Brophy Wealth Management’s Amgen AMGN Stock Holding History

Brophy Wealth Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$1.31M	Buy	+4,071	New	+$1.33M	0.47%	45

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Brophy Wealth Management's AMGN Position: Q3 2024 in Review

Brophy Wealth Management opened a new position in Amgen (AMGN) in Q3 2024: 4,071 shares worth $1.31M. The stake represents 0.47% of the portfolio and ranks #45 among its holdings.

2,824 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

Brophy Wealth Management held 4,071 shares of Amgen worth $1.31M as of Q3 2024.
Amgen was a new Brophy Wealth Management position in Q3 2024.
Amgen made up 0.47% of Brophy Wealth Management's portfolio in Q3 2024, its #45 holding.
2,824 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on Brophy Wealth Management's 13F filing for Q3 2024, filed 15 Nov 2024.